Rosa Gini

4.0k total citations
123 papers, 2.3k citations indexed

About

Rosa Gini is a scholar working on Epidemiology, Toxicology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rosa Gini has authored 123 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 18 papers in Toxicology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rosa Gini's work include Pharmacovigilance and Adverse Drug Reactions (18 papers), Chronic Disease Management Strategies (11 papers) and Pregnancy and Medication Impact (10 papers). Rosa Gini is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (18 papers), Chronic Disease Management Strategies (11 papers) and Pregnancy and Medication Impact (10 papers). Rosa Gini collaborates with scholars based in Italy, Netherlands and United Kingdom. Rosa Gini's co-authors include Miriam Sturkenboom, Martijn J. Schuemie, Giampiero Mazzaglia, Gianluca Trifirò, Johan van der Lei, Preciosa M. Coloma, Ron M. C. Herings, Lars Pedersen, Gino Picelli and Julia Hippisley–Cox and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Rosa Gini

118 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosa Gini Italy	26	408	401	382	322	294	123	2.3k
Gerald J. Dal Pan United States	30	598 1.5×	709 1.8×	494 1.3×	429 1.3×	501 1.7×	106	4.1k
Melissa A. Robb United States	10	193 0.5×	555 1.4×	272 0.7×	235 0.7×	147 0.5×	12	2.2k
Preciosa M. Coloma Netherlands	25	673 1.6×	247 0.6×	131 0.3×	264 0.8×	192 0.7×	46	1.9k
Xavier Kurz Netherlands	31	321 0.8×	520 1.3×	279 0.7×	281 0.9×	226 0.8×	92	3.5k
Ju‐Young Shin South Korea	27	272 0.7×	259 0.6×	234 0.6×	535 1.7×	287 1.0×	303	3.0k
Stephan Lanes United States	29	383 0.9×	198 0.5×	252 0.7×	438 1.4×	174 0.6×	98	4.3k
Graham Jones Australia	31	265 0.6×	128 0.3×	271 0.7×	304 0.9×	233 0.8×	151	4.1k
Mariam Molokhia United Kingdom	30	489 1.2×	325 0.8×	201 0.5×	733 2.3×	370 1.3×	89	3.8k
Charles E. Leonard United States	26	227 0.6×	191 0.5×	185 0.5×	203 0.6×	163 0.6×	127	2.3k
Joerg Hasford Germany	41	648 1.6×	409 1.0×	790 2.1×	200 0.6×	659 2.2×	188	7.0k

Countries citing papers authored by Rosa Gini

Since Specialization

Citations

This map shows the geographic impact of Rosa Gini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Gini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Gini more than expected).

Fields of papers citing papers by Rosa Gini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Gini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Gini. The network helps show where Rosa Gini may publish in the future.

Co-authorship network of co-authors of Rosa Gini

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Gini. A scholar is included among the top collaborators of Rosa Gini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Gini. Rosa Gini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lastrucci, Vieri, Elettra Berti, Marco Del Riccio, et al.. (2024). Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study. International Journal of Infectious Diseases. 148. 107231–107231. 11 indexed citations

Tazare, John, Shirley Wang, Rosa Gini, et al.. (2024). Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming Code. Pharmacoepidemiology and Drug Safety. 33(9). e5856–e5856. 2 indexed citations

Gini, Rosa, Romin Pajouheshnia, Helga Gardarsdóttir, et al.. (2024). Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review. Pharmacoepidemiology and Drug Safety. 33(5). e5787–e5787. 3 indexed citations

Convertino, Irma, Massimiliano Cazzato, Rosa Gini, et al.. (2023). Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy. Frontiers in Pharmacology. 14. 1244486–1244486.

Roberto, Giuseppe, Sara Ferraro, Massimo Franchini, et al.. (2023). Cases of acquired hemophilia A following COVID‐19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy. Pharmacoepidemiology and Drug Safety. 32(6). 694–699. 2 indexed citations

Crescioli, Giada, Sandra Donnini, Marina Ziche, et al.. (2022). Sex differences in the utilization of drugs for COVID‐19 treatment among elderly residents in a sample of Italian nursing homes. Pharmacoepidemiology and Drug Safety. 31(5). 489–494. 2 indexed citations

Antonazzo, Ippazio Cosimo, Carla Fornari, Sandy Maumus‐Robert, et al.. (2022). Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis. Journal of Personalized Medicine. 12(2). 178–178. 9 indexed citations

Convertino, Irma, Rosa Gini, Massimiliano Cazzato, et al.. (2021). Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study. Journal of Clinical Medicine. 10(24). 5743–5743. 3 indexed citations

Massari, Marco, Stefania Spila Alegiani, Massimo Fabiani, et al.. (2021). Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study. Vaccines. 9(7). 716–716. 10 indexed citations

10.

Ingrasciotta, Ylenia, Janet Sultana, Valentina Ientile, et al.. (2020). Direct healthcare costs of chronic kidney disease management in Italy: What cost‐savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis‐stimulating agents?. Pharmacoepidemiology and Drug Safety. 30(1). 65–77. 4 indexed citations

11.

Bollaerts, Kaatje, et al.. (2020). Disease misclassification in electronic healthcare database studies: Deriving validity indices—A contribution from the ADVANCE project. PLoS ONE. 15(4). e0231333–e0231333. 11 indexed citations

12.

Pogam, Marie‐Annick Le, Amy Metcalfe, Pia Kjær Kristensen, et al.. (2020). Empowering knowledge generation through international data network: the IMeCCHI-DATANETWORK. International Journal for Population Data Science. 5(1). 1125–1125. 2 indexed citations

13.

Hall, Gillian C., Stephan Lanes, Kaatje Bollaerts, et al.. (2020). Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence. Pharmacoepidemiology and Drug Safety. 29(11). 1450–1455. 15 indexed citations

14.

Belleudi, Valeria, Francesco Trotta, Antonio Addis, et al.. (2019). Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study. Drug Safety. 42(12). 1437–1447. 17 indexed citations

15.

Gini, Rosa, Helen Dolk, Xavier Kurz, et al.. (2019). The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies. Pharmacoepidemiology and Drug Safety. 28(4). 422–433. 10 indexed citations

16.

Gini, Rosa, Martijn J. Schuemie, Alessandro Pasqua, et al.. (2017). Monitoring compliance with standards of care for chronic diseases using healthcare administrative databases in Italy: Strengths and limitations. PLoS ONE. 12(12). e0188377–e0188377. 6 indexed citations

17.

Gini, Rosa, Martijn J. Schuemie, Giampiero Mazzaglia, et al.. (2016). Automatic identification of type 2 diabetes, hypertension, ischaemic heart disease, heart failure and their levels of severity from Italian General Practitioners' electronic medical records: a validation study. BMJ Open. 6(12). e012413–e012413. 24 indexed citations

18.

Molero, Eva, Ferrán Sanz, José Luís Oliveira, et al.. (2012). the Eu-adr Alliance: A Federated Collaborative Framework for Drug Safety Studies : 667.. Pharmacoepidemiology and Drug Safety. 21. 311–312. 1 indexed citations

19.

Barone‐Adesi, Francesco, et al.. (2009). [Young epidemiologists between insecurity and tenure].. PubMed. 33(1-2). 13–9. 1 indexed citations

20.

Pigatto, Paolo D., Rosa Gini, & G. F. Altomare. (1985). ALOPECIA AREATA E TRATTAMENTO CON DIETILESTERE DELL'ACIDO SQUARICO (DEAS). COMPORTAMENTO DELLE SOTTOPOPOLAZIONI LINFOCITARIE. Redia-Giornale Di Zoologia. 120(3). 227–230. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact